Kyri K. Van Hoose insider trades
Open-market stock purchases and sales by Kyri K. Van Hoose, SVP, CFO at Dermata Therapeutics, Inc, from SEC Form 4 filings since Sep 1, 2021.
Recent trades
Companies traded
- DRMA Dermata Therapeutics, Inc: other filings, last Jan 2, 2026